A new, fast and reliable radioimmunoassay of brain natriuretic peptide in human plasma. Reference values in healthy subjects and in patients with different diseases

Scandinavian Journal of Clinical and Laboratory Investigation

Volumn 57, Issue 6, 1997, Pages 529-540

  Jensen, K T ^a   Carstens, J ^a   Ivarsen, P ^a   Pedersen, E B ^a  

^a AARHUS UNIVERSITY HOSPITAL   (Denmark)

Author keywords

Chronic renal failure; Circadian rhythm; Congestive heart failure; Cross reactivity; Essential hypertension; HPLC; Human; Immunisation; Iodogen method; Liver cirrhosis

Indexed keywords

BRAIN NATRIURETIC PEPTIDE;

ARTICLE; CHRONIC KIDNEY FAILURE; CONGESTIVE HEART FAILURE; CONTROLLED STUDY; DRUG BLOOD LEVEL; DRUG DETERMINATION; ESSENTIAL HYPERTENSION; HUMAN; HUMAN TISSUE; LIVER CIRRHOSIS; PRIORITY JOURNAL; RADIOIMMUNOASSAY; TECHNIQUE;

EID: 0030816227     PISSN: 00365513     EISSN: None     Source Type: Journal    
DOI: 10.3109/00365519709084604     Document Type: Article

References (23)

1. Sudoh T, Kangawa K, Minamino N, Matsuo H. A new natriuretic peptide in porcine brain. Nature 1988; 332: 78-81.
2. Togashi K, Kameya T, Ando K, Marumo F, Kawakami M. Brain natriuretic peptides in human plasma, spinal cord and cerebrospinal fluid. Clin Chim Acta 1991; 201: 193-200.
3. Mukoyama M, Nakao K, Hosoda K, Suga S, Saito Y, Ogawa Y, et al. Brain natriuretic peptide as a novel cardiac hormone in humans. Evidence for an exquisite dual natriuretic peptide system, atrial natriuretic peptide and brain natriuretic peptide. J Clin Invest 1991; 87: 1402-12.
4. McGregor A, Richards M, Espiner E, Yandle T, Ikram H. Brain natriuretic peptide administered to man: actions and metabolism. J Clin Endocrinol Metab 1990; 70: 1103-7.
5. La Villa G, Stefani L, Lazzeri C, Zurli C, Guerra CT, Barletta G, et al. Acute effects of physiological increments of brain natriuretic peptide in humans. Hypertension 1995; 26: 628-33.
6. Okumura K, Yasue H, Fujii H, Kugiyama K, Matsuyama K, Yoshimura M, et al. Effects of brain (B-type) natriuretic peptide on coronary artery diameter and coronary hemodynamic variables in humans: comparison with effects on systemic hemodynamic variables. J Am Coll Cardiol 1995; 25: 342-8.
7. Florkowski CM, Richards AM, Espiner EA, Yandle TG, Frampton C. Renal, endocrine, and hemodynamic interactions of atrial and brain natriuretic peptides in normal men. Am J Physiol 1994; 266: R1244-50.
8. Holmes SJ, Espiner EA, Richards AM, Yandle TG, Frampton C. Renal, endocrine, and hemodynamic effects of human brain natriuretic peptide in normal man. J Clin Endocrinol Metab 1993; 76: 91-6.
9. Yoshimura M, Yasue H, Morita E, Sakaino N, Jougasaki M, Kurose M, et al. Hemodynamic, renal, and hormonal responses to brain natriuretic peptide infusion in patients with congestive heart failure. Circulation 1991; 84: 1581-8.
10. Nakamura S, Naruse M, Naruse K, Kawana M, Nishikawa T, Hosoda S, et al. Atrial natriuretic peptide and brain natriuretic peptide coexist in the secretory granules of human cardiac myocytes. Am J Hypertens 1991; 4: 909-12.
11. Pucci A, Wharton J, Arbustini E, Grasso M, Diegoli M, Needleman P, et al. Localization of brain and atrial natriuretic peptide in human and porcine heart. Int J Cardiol 1992; 34: 237-47.
12. Yasue H, Yoshimura M, Sumida H, Kikuta K, Kugiyama K, Jougasaki M, et al. Localization and mechanism of secretion of B-type natriuretic peptide in comparison with those of A-type natriuretic peptide in normal subjects and patients with heart failure. Circulation 1994; 90: 195-203.
13. Naruse M, Takeyama Y, Tanabe A, Hiroshige J, Naruse K, Yoshimoto T, et al. Atrial and brain natriuretic peptides in cardiovascular diseases. Hypertension 1994; 23: I231-4.
14. Buckley MG, Markandu NG, Miller MA, Sagnella GA, MacGregor GA. Plasma concentrations and comparisons of brain and atrial natriuretic peptide in normal subjects and in patients with essential hypertension. J Hum Hypertens 1993; 7: 245-50.
15. Ishizaka Y, Yamamoto Y, Tanaka M, Kato F, Yokota N, Kato J, et al. Molecular forms of human brain natriuretic peptide (BNP) in plasma of patients on hemodialysis (HD). Clin Nephrol 1995; 43: 237-42.
16. Wei CM, Heublein DM, Perrella MA, Lerman A, Rodeheffer RJ, McGregor CG, et al. Natriuretic peptide system in human heart failure. Circulation 1993; 88: 1004-9.
17. Buckley MG, Sethi D, Markandu ND, Sagnella GA, Singer DR, MacGregor GA. Plasma concentrations and comparisons of brain natriuretic peptide and atrial natriuretic peptide in normal subjects, cardiac transplant recipients and patients with dialysis-independent or dialysis-dependent chronic renal failure. Clin Sci Colch 1992; 83: 437-44.
18. Kohno M, Horio T, Yokokawa K, Yasunari K, Ikeda M, Minami M, et al. Brain natriuretic peptide as a marker for hypertensive left ventricular hypertrophy: changes during 1-year anti-hypertensive therapy with angiotensin-converting enzyme inhibitor. Am J Med 1995; 98: 257-65.
19. Lang CC, Motwani JG, Coutie WJ, Struthers AD. Clearance of brain natriuretic peptide in patients with chronic heart failure: indirect evidence for a neutral endopeptidase mechanism but against an atrial natriuretic peptide clearance receptor mechanism. Clin Sci Colch 1992; 82: 619-23.
20. Yandle TG, Richards AM, Gilbert A, Fisher S, Holmes S, Espiner EA. Assay of brain natriuretic peptide (BNP) in human plasma: evidence for high molecular weight BNP as a major plasma component in heart failure. J Clin Endocrinol Metab 1993; 76: 832-8.
21. Hunt PJ, Yandle TG, Nicholls MG, Richards AM, Espiner EA. The amino-terminal portion of probrain natriuretic peptide (Pro-BNP) circulates in human plasma. Biochem Biophys Res Commun 1995; 214: 1175-83.
22. Tateyama H, Hino J, Minamino N, Kangawa K, Minamino T, Sakai K, et al. Concentrations and molecular forms of human brain natriuretic peptide in plasma. Biochem Biophys Res Commun 1992; 185: 760-7.
23. Rasmussen PH, Bruun NE, Giese J. Comparison of different standards used in radioimmunoassay for atrial natriuretic factor (ANF). Scand J Clin Invest 1991; 51: 533-9.